105
Participants
Start Date
June 30, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Lurasidone
Lurasidone 20, 40,80, 120 or 160 mg/day oral single and multiple does of lurasidone for 12 days
CRI Worldwide, LLC, Philadelphia
Atlanta Center for Medical Research, Atlanta
Miami Children's Hospital, South Miami
Segal Institute for Clinical Research, Fort Lauderdale
University Hospitals Case Medical Center, Cleveland
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience, Cincinnati
Woodland International Research Group, Inc., Little Rock
Woodland Northwest Research, LLC, Springdale
Aspen Clinical Research, Orem
World Wide Research Centers Inc., Murrieta
Sumitomo Pharma America, Inc.
INDUSTRY